What is Liraglutide (Saxenda / Victoza) used for?
Liraglutide (Saxenda / Victoza) is most commonly used for patients on insurance plans that cover Saxenda but not Wegovy; users who don't tolerate weekly Semaglutide titration; educational reference for the GLP-1 class lineage. Daily GLP-1 receptor agonist. FDA-approved 2010 (Victoza, T2D) and 2014 (Saxenda, obesity). The first wave of modern GLP-1 weight-loss therapy and direct predecessor to Semaglutide. Human evidence for Liraglutide (Saxenda / Victoza) is limited, so these are the goals people pursue with it, not guaranteed outcomes.
What people use Liraglutide (Saxenda / Victoza) for
- Patients on insurance plans that cover Saxenda but not Wegovy
- Users who don't tolerate weekly Semaglutide titration
- Educational reference for the GLP-1 class lineage
References
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE Obesity) — Pi-Sunyer X et al., NEJM, 2015
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (LEADER) — Marso SP et al., New England Journal of Medicine, 2016
- Victoza (liraglutide) — Drugs@FDA approval record (ApplNo 022341) — FDA, Drugs@FDA
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Liraglutide (Saxenda / Victoza)
Full Liraglutide (Saxenda / Victoza) breakdownLiraglutide (Saxenda / Victoza) side effectsLiraglutide (Saxenda / Victoza) how to take itLiraglutide (Saxenda / Victoza) mistakes to avoidLiraglutide (Saxenda / Victoza) who should avoid itLiraglutide (Saxenda / Victoza) half-lifeLiraglutide (Saxenda / Victoza) how long to workLiraglutide (Saxenda / Victoza) legal statusLiraglutide (Saxenda / Victoza) how it worksAsk the AI Coach
Last updated 2026-06-15.